Patrick Truesdell
No más puestos en curso
Fortuna: - $ al 30/04/2024
Perfil
Patrick Truesdell served as Chief Accounting Officer, VP & Controller at Landos Biopharma, Inc. from 2022 to 2023.
Prior to that, he was Vice President-Finance & Controller at Gemini Therapeutics, Inc. from 2021 to 2022.
Truesdell received a graduate degree from the University of Illinois and undergraduate and MBA degrees from Tippie College of Business.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LANDOS BIOPHARMA, INC.
-.--% | 31/03/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Antiguos cargos conocidos de Patrick Truesdell.
| Empresas | Cargo | Fin |
|---|---|---|
| LANDOS BIOPHARMA, INC. | Contacto de Relaciones con Inversores | 10/11/2023 |
| GEMI THER | Comptroller/Controller/Auditor | 01/04/2022 |
Formación de Patrick Truesdell.
| Tippie College of Business | Masters Business Admin |
| University of Illinois | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| LANDOS BIOPHARMA, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Gemini Therapeutics, Inc.
 Gemini Therapeutics, Inc. BiotechnologyHealth Technology Gemini Therapeutics, Inc. is a clinical-stage precision medicine company. It is developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration. The company was founded by Johanna Seddon, Paul Barlow and Andrew Herbert on March 3, 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Patrick Truesdell
